VJOncology

VJOncology Podcast

Health EN ↓ 242 episodes

The Video Journal of Oncology (VJOncology) podcast covers the latest solid oncology news from international experts, including breast, lung, skin, genitourinary, head and neck, gynecological and more! Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com

Be sure to visit the podcast's website and support the creator: vjoncology.podbean.com

Author

VJOncology

Category

Health

Podcast website

vjoncology.podbean.com

Latest episode

Nov 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Prostate Cancer Highlights from ESMO 2021 from Robert Jones 28.10.2021

The European Society for Medical Oncology (ESMO) 2021 Congress saw many exciting clinical trials presented from across the field of oncology, some of which are paving the way for new standards of care for patients. Among the biggest readouts for the field of prostate cancer were the STAMPEDE (NCT00268476), PEACE-1 (NCT01957436), and ARCHES (NCT02677896) studies. In this podcast, we are joined by R...

The GU Cancer Sessions: Bladder Highlights from ESMO 2021 19.10.2021

VJOncology has assembled a group of leading genitourinary cancer experts to examine and discuss the exciting developments in bladder cancer presented at the European Society for Medical Oncology (ESMO) 2021 Annual Meeting. Listen to this insightful roundtable discussion featuring Laurence Albiges, Gustave Roussy Institute, Villejuif, France, and Enrique Grande, MD Anderson Cancer Center Madrid, Ma...

The Lung Cancer Sessions: Highlights from ASCO 2021 22.09.2021

Following the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, VJOncology brought together a group of leading lung cancer experts to offer their perspectives on the latest research advances presented at the meeting and how they could impact lung cancer care in the future. In this exclusive post-ASCO podcast, Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, is j...

The GI Cancer Sessions: Highlights from ASCO 2021 22.09.2021

At the virtual 2021 American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, important advances and potentially practice-changing trial data were presented in a range of gastrointestinal (GI) malignancies such as esophageal, gastric and colorectal cancer. VJOncology has assembled an esteemed panel of leading GI experts to discuss the latest exciting developments, what these advances could...

The Skin Cancer Sessions: Highlights from ASCO 2021 22.09.2021

VJOncology has assembled a panel of world-renowned skin cancer experts to examine and discuss the exciting advances in skin cancer presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. In this exclusive podcast, James Larkin, MD, PhD, Royal Marsden Hospital, London, UK, is joined by Rodabe Amaria, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Ana...

Key clinical trial data in urothelial carcinoma at ASCO 2021 10.09.2021

Chemotherapy is central to the treatment of advanced or metastatic urothelial carcinoma (UC), and platinum-based treatments, like cisplatin, have been the first-line treatment options for many years. To address the limitations of platinum-based chemotherapeutics, additional therapeutics have become available in more recent years for first- and second-line use. Specifically, for patients who are ci...

Prostate Cancer Highlights from ASCO 2021 with Pedro Barata 23.08.2021

This year, at the American Society of Clinical Oncology (ASCO) Virtual Meeting 2021, experts came together virtually to present and discuss the latest findings in oncology. In this podcast, Pedro Barata, MD, MSc Tulane University School of Medicine, New Orleans, LA, discusses highlights from the meeting. He focuses on the results from four Phase III trials assessing various therapies for the treat...

The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO 2021 16.08.2021

During the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, an exciting array of advances in genitourinary (GU) cancer research were presented. VJOncology has brought together a panel of leading GU experts to consider and debate the latest developments in bladder and kidney cancer and offer their perspectives on how they could impact patient care in the future.   This post-ASCO GU...

The Breast Cancer Sessions: Highlights from ASCO 2021 16.08.2021

VJOncology has assembled an international panel of leading breast cancer experts to discuss the latest advances and data from the virtual American Society of Clinical Oncology (ASCO) 2021 Annual Meeting. In this podcast, Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, is joined by Giuseppe Curigliano, MD, University of Milan, Milan, Italy, Sara Tolaney, MD, MPH, Dana-Farber Can...

ASCO 2021: Immunotherapy updates in lung cancer 04.08.2021

Various immunotherapies including checkpoint inhibitors have emerged as effective treatment options for patients with non-small cell lung cancer (NSCLC). Immune checkpoints proteins such as PD-1, PD-L1 and CTLA-4 have become promising targets, as they have an immunosuppressive function and are overexpressed in certain cancers. Several checkpoint inhibitors have already received FDA approval includ...

EAU 2021: updates in testicular cancer 28.07.2021

Whilst advances in diagnostic procedures, radiotherapies, cisplatin-based chemotherapy, and surgery have meant that testicular cancer is curable in around 95% of cases, the side effects of radiotherapy and chemotherapy can significantly impact quality-of-life (QoL) outcomes for patients treated for testicular cancer in both the short and long term. Currently, much research is investigating how nov...

Highlights from ESMO WCGIC 2021: VALENTINO, KEYNOTE-811 & BEACON-CRC 15.07.2021

The ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2021 annual meeting took place virtually this year and leading experts came together to present on the most recent developments in GI cancer. In this podcast, Paolo Manca, MD, Istituto Nazionale dei Tumori Milano, Milano, Italy, Yelena Janjigian, MD, Memorial Sloan Kettering Cancer Center, New York, NY, and Dan Aderka, MD, Sheba Medical Ce...

What's new? Treating breast cancer with brain metastases 14.07.2021

Metastatic breast cancer is breast cancer that has spread to other regions of the body, most commonly the liver, brain, bones, or lungs. Cancer cells migrate from the original tumor site in the breast and travel to other regions in the body through the bloodstream or lymphatic system. Although significant developments have been made in the treatment options available for patients with metastatic b...

Global breast cancer care 13.07.2021

Healthcare systems around the world differ in financial and political situations. Therefore, it is vital to implement a global outlook of breast cancer care that focuses on applying access to high-quality practices, especially in low- and middle-income countries, where breast cancer remains a public health crisis.    During this podcast, Andre Ilbawi, MD, of the World Health Organization (WHO), Ca...

Latest developments in immunotherapy for patients with melanoma 01.07.2021

Surgery is an effective treatment for non-metastatic melanoma, however, advanced melanoma demands additional intervention, such as chemotherapy or immunotherapy. The development of immunotherapies for melanoma has significantly improved outcomes for patients with metastatic cancer. Several immunotherapies for metastatic melanoma have already received FDA approval, including nivolumab and ipilimuma...

ASCO 2021: PSMA-targeted radionuclide therapy for prostate cancer 25.06.2021

Prostate-specific membrane antigen (PSMA) is overexpressed in more than 80% of  prostate cancer  tumors, making it a promising diagnostic and therapeutic target. Given the highly limited expression of PSMA outside of the prostate, precision approaches that specifically target PSMA have been of substantial interest in the field. PSMA-targeted radionuclide therapy combines a PSMA ligand with a radio...

ESMO Breast 2021: updates on immunotherapy 10.06.2021

Breast cancer is the most common type of cancer in women. Although most cases of early-stage non-metastatic disease are curable with surgery, effective treatments for later-stage and metastatic disease remain an unmet need. Several immunotherapies have received FDA approval for the treatment of breast cancer, including pembrolizumab, atezolizumab and trastuzumab deruxtecan. In this podcast, Rebecc...

The Lung Cancer Sessions: Highlights from BTOG 2021 03.06.2021

VJOncology has assembled a panel of world-renowned experts, who offer their perspectives on the latest developments in lung cancer presented at the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021.  In this podcast, Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust London, UK, is joined by Samreen Ahmed, MBBS, MSc(onc), FRCP, MD, University Hospitals of L...

Sequencing HER2-targeting therapies in the metastatic breast cancer space 14.05.2021

Treatment approaches in breast cancer are multimodal, and with the onset of novel immunotherapies and targeted agents, the therapeutic landscape of patients with advanced disease has expanded. In HER2+ disease, the treatment landscape has become saturated with novel HER2-targeting agents, bringing into question how these agents should be sequenced for maximum benefit to patients. In this podcast,...

The GU Sessions: Prostate Cancer Highlights from ASCO GU 2021 13.05.2021

The 2021 American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium showcased a range of exciting clinical trial data and major milestones in prostate cancer. VJOncology has bought together a team of leading experts in prostate cancer to explore their insights on key updates from this meeting. In this exclusive podcast, Neal Shore, MD, FACS, Carolina Urologic Research Center, SC w...

Latest news in GU: CAR-T in RCC, updates from IMvigor130, & liquid biopsies in prostate cancer 13.05.2021

The American Association for Cancer Research Annual Meeting 2021 (AACR) took place virtually this year and showcased an array across the spectrum of cancer research, from cancer biology to translational studies and trial updates. In this podcast, we hear from three leading experts in genitourinary cancer and their insights from the AACR annual meeting. Yufei Wang, PhD, Dana-Farber Cancer Institute...

The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO GU 2021 13.05.2021

VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest bladder and kidney cancer data presented at the American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium, which was held virtually in February 2021. In this podcast, Arlene Siefker-Radtke, MD, University of Texas MD Anderson Cancer Center, Houston, TX, is joined by Alison Birtle, MRCP...

BTOG 2021: KRAS targeting and oncogenically-driven lung cancer 12.05.2021

Traditional treatments for lung cancer include chemotherapy, radiotherapy and surgery, however the identification of oncogenic drivers, such as EGFR, ALK and ROS1, offers the potential for novel targeted therapies and personalized approaches to lung cancer treatment. Numerous studies and trials are underway which are investigating therapies targeting oncogenes including KRAS, PD-1/PD-L1 and JAK2,...

The Breast Cancer Sessions: a focus on the St. Gallen Consensus 26.04.2021

At the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned St. Gallen International Consensus Session on the optimal treatment of early breast cancer.  In this podcast, St. Gallen Consensus Session Co-Chair Giuseppe Curigliano, MD, PhD, European Institute of Oncology & University of Milan, Milan, Italy, is joined by consensus...

Predictive and prognostic biomarkers in breast cancer 07.04.2021

Following a breast cancer diagnosis, the most immediate challenges in patient management are the determination of prognosis and identification of the most appropriate adjuvant systemic therapy, the most valid of these tests include Oncotype DX and MammaPrint. In the identification of new predictive and prognostic markers, research efforts are focusing on the clinical utility of circulating and tum...

Listen to the VJOncology Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.